Airway pressure release ventilation versus low tidal volume ventilation for patients with acute respiratory distress syndrome/acute lung injury: a meta-analysis of randomized clinical trials

作者
Xi Zoë Zhong,Qin Wu,Hao Yang,Wei Dong,Bo Wang,Zhongwei Zhang,Guopeng Liang
出处
期刊:Annals of Translational Medicine [AME Publishing Company]
卷期号:8 (24): 1641-1641 被引量:36
标识
DOI:10.21037/atm-20-6917
摘要

BACKGROUND: It is uncertain whether airway pressure release ventilation (APRV) is better than low tidal volume ventilation (LTVV) for patients with acute respiratory distress syndrome (ARDS). The purpose of this meta-analysis was to compare APRV and LTVV on patients with ARDS. METHODS: Randomized controlled trials (RCTs) comparing outcomes in ARDS ventilator therapy with APRV or LTVV were identified using Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica Database (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, the Cochrane Library, and The Chinese Biomedicine Literature Database (SinoMed) from inception to March 2019. RESULTS: A total of 7 RCTs with a 405 patients were eligible for our meta-analysis. The results revealed that APRV was associated with lower hospital mortality [405 patients; odds ratio (OR), 0.57; 95% confidence interval (CI), 0.37-0.88; P=0.01], a shorter time of ventilator therapy [373 patients; mean difference (MD), 5.36; 95% CI, 1.99-8.73; P=0.002], and intensive care unit (ICU) stay (315 patients; MD, -4.50; 95% CI, -6.56 to -2.44; P<0.0001), better respiratory system compliance on day 3 (202 patients; MD, 8.19; 95% CI, 0.84-15.54; P=0.03), arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) on day 3 (294 patients; MD, 44.40; 95% CI, 16.05-72.76; P=0.002), and higher mean arterial pressure (MAP) on day 3 (285 patients; MD, 4.18; 95% CI, 3.10-5.25; P<0.00001). There was no statistical difference in the incidence of pneumothorax (170 patients; OR, 0.40; 95% CI, 0.12-1.34; P=0.14). CONCLUSIONS: The meta-analysis showed that APRV could reduce hospital mortality, duration of ventilation and ICU stay, improve lung compliance, oxygenation index, and MAP compared with LTVV for patients with ARDS. We found APRV to be a safe and effective ventilation mode for patients with ARDS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
领导范儿的应助被sharon采纳,获得10
刚刚
hi_traffic发布了新的文献求助10
刚刚
椰子水水完成签到,获得积分20
刚刚
秋风的应助被jerrychen采纳,获得10
刚刚
周小鱼发布了新的文献求助10
刚刚
刚刚
在水一方的应助被Lotus采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
内向易文发布了新的文献求助10
1秒前
1秒前
Pf1314发布了新的文献求助100
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
fantasy的应助被科研通管家采纳,获得10
1秒前
Jyu的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
NexusExplorer的应助被科研通管家采纳,获得10
2秒前
情怀的应助被科研通管家采纳,获得10
2秒前
2秒前
Owen的应助被科研通管家采纳,获得10
2秒前
桐桐的应助被科研通管家采纳,获得10
2秒前
酷波er的应助被科研通管家采纳,获得10
2秒前
2秒前
ding的应助被科研通管家采纳,获得10
2秒前
脑洞疼的应助被长情的初曼采纳,获得10
2秒前
在水一方的应助被科研通管家采纳,获得10
2秒前
小晶发布了新的文献求助10
2秒前
Jyu的应助被科研通管家采纳,获得10
2秒前
molihuakai的应助被科研通管家采纳,获得10
3秒前
慕青的应助被科研通管家采纳,获得10
3秒前
fantasy的应助被科研通管家采纳,获得30
3秒前
思源的应助被科研通管家采纳,获得100
3秒前
上官若男的应助被科研通管家采纳,获得10
3秒前
秋风的应助被科研通管家采纳,获得10
3秒前
3秒前
西北一枝花的应助被jing采纳,获得10
3秒前
3秒前
怡然破茧完成签到,获得积分10
4秒前
星辰大海的应助被科研通管家采纳,获得10
4秒前
汉堡包的应助被科研通管家采纳,获得10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417